Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Wound Repair Regen ; 20(2): 178-84, 2012.
Article in English | MEDLINE | ID: mdl-22304391

ABSTRACT

A new effective surgical procedure to repair chronic ulcers called minced micrografts technique has been recently reported. The technique consists in spreading a finely minced skin sample upon the wound bed. In this study, we investigate the in vitro release of cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1α, and granulocyte-colony stimulating factor), chemokines (monocyte chemoattractant protein-1 and growth-related oncogene-α), and growth factors (platelet-derived growth factor, basic fibroblast growth factor, vascular endothelial growth factor, hepatocyte growth factor, and nerve growth factor) by minced (referred to as the minced sample) vs. not minced (referred to as the whole sample) human skin biopsy samples from the same donor. Factor release in the culture medium at different time points was detected using a multiplexed protein assay. The minced sample, which could behave like the skin fragments used in vivo in the autologous minced micrografts technique, expressed higher levels of tumor necrosis factor-α, interleukin-1α, platelet-derived growth factor, and basic fibroblast growth factor, and lower levels of interleukin-6, monocyte chemoattractant protein-1, growth related oncogene-α, and vascular endothelial growth factor compared with the whole sample. In conclusion, mincing of healthy skin may allow appropriate regulation of the inflammatory phase of wound healing and could induce overexpression of some growth factors, which facilitates the proliferative phase of healing.


Subject(s)
Chemokines/metabolism , Cytokines/metabolism , Dermatologic Surgical Procedures , Intercellular Signaling Peptides and Proteins/metabolism , Leg Ulcer/surgery , Transplantation, Autologous , Wound Healing , Aged , Female , Granulocyte Colony-Stimulating Factor/metabolism , Humans , Leg Ulcer/metabolism , Leg Ulcer/physiopathology , Male , Middle Aged , Skin/metabolism , Skin/physiopathology , Skin Transplantation/methods , Tissue Culture Techniques
2.
Mol Cell Neurosci ; 45(2): 85-91, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20538057

ABSTRACT

Beta-amyloid peptide (betaAP) induces apoptosis and down-regulation of alpha(1)beta(1) integrin in neuronal cells, indicating a relationship between betaAP neurotoxicity and modulation of integrin expression. Estrogen may play a role in protecting women from Alzheimer Disease (AD). It is here reported that both 17beta-estradiol (17betaE(2)) and its non-estrogenic stereoisomer 17alpha-estradiol (17alphaE(2)) rescue neuronal cells from betaAP-induced apoptosis. As cellular model, the human neuroblastoma cell line SK-N-BE was used, which responds to retinoic acid by growth arrest and differentiation toward the neuronal phenotype (RA-SK-N-BE). Estrogen receptor antagonist does not hinder estrogen protection. Inhibition of phosphatidylinositol 3-kinase (PI3-K), but not of tyrosine kinases or mitogen-activated protein kinases (MAPK) blocks 17betaE(2) protection against betaAP-induced apoptosis. 17betaE(2) up-regulates alpha(1)beta(1) integrin expression and completely abolishes betaAP-induced alpha(1)beta(1) down-regulation. Inadequate cell cycle control may contribute to neuronal death in AD. betaAP induces RA-SK-N-BE cells to enter cell cycle, which remains incomplete. 17betaE(2) induces betaAP-treated cells to complete cell cycle. Our data suggest that estrogen protects from betaAP neurotoxicity by restoring integrin expression and cell cycle control.


Subject(s)
Amyloid beta-Peptides/metabolism , Apoptosis/drug effects , Cytoprotection , Estradiol/pharmacology , Integrin alpha1beta1/metabolism , Neurons/drug effects , Phosphatidylinositol 3-Kinases/metabolism , Amyloid beta-Peptides/adverse effects , Cell Line, Tumor , Down-Regulation/drug effects , Estradiol/physiology , Humans , Integrin alpha1beta1/analysis , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Mitogen-Activated Protein Kinases/metabolism , Neurons/metabolism , Phosphoinositide-3 Kinase Inhibitors , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Receptors, Estrogen/antagonists & inhibitors , Up-Regulation/drug effects
3.
Nutrients ; 12(2)2020 Feb 22.
Article in English | MEDLINE | ID: mdl-32098378

ABSTRACT

Background: Magnesium is involved in a wide variety of physiological processes including direct relaxation of smooth muscle. A magnesium imbalance can be considered the primary cause or consequence of many pathophysiological conditions. The smooth muscle tissue of the uterus, i.e., the myometrium, undergoes numerous physiological changes during life, fundamental for uterine activities, and it receives proven benefits from magnesium supplementation. However, magnesium supplements have poor absorption and bioavailability. Furthermore, no data are available on the direct interaction between intestinal absorption of magnesium and relaxation of the myometrium. Methods: Permeability in human intestinal cells (Caco-2 cells) and direct effects on myometrial cells (PHM1-41 cells) of two different forms of magnesium, i.e., sucrosomial and bisglycinate, were studied in order to verify the magnesium capacity of modulate contractility. Cell viability, reactive oxygen species (ROS) and nitric oxide (NO) production, magnesium concentration, contractility, and pathways involved were analyzed. Results: Data showed a better influence of buffered chelate bisglycinate on intestinal permeability and myometrial relaxation over time with a maximum effect at 3 h and greater availability compared to the sucrosomial form. Conclusions: Magnesium-buffered bisglycinate chelate showed better intestinal absorption and myometrial contraction, indicating a better chance of effectiveness in human applications.


Subject(s)
Chelating Agents/pharmacology , Dietary Supplements , Intestinal Mucosa/metabolism , Magnesium/pharmacology , Uterine Contraction/drug effects , Biological Availability , Caco-2 Cells , Chelating Agents/chemistry , Female , Humans , Intestinal Absorption/drug effects , Magnesium/chemistry , Muscle, Smooth/drug effects , Muscle, Smooth/physiology , Myometrium/cytology , Myometrium/drug effects , Myometrium/physiology , Permeability
4.
Arch Dermatol Res ; 309(3): 179-189, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28229230

ABSTRACT

The pathogenicity of Mycobacterium ulcerans (Buruli ulcer) is closely associated with the secretion of exotoxin mycolactone. The cytotoxicity of mycolactone has been linked to its apoptogenic activity. We explored if low mycolactone concentrations, which are not able to induce apoptosis, can influence other essential activities on two primary human keratinocyte populations, keratinocyte stem cells (KSC) and transit amplifying cells (TAC), and on a human keratinocyte line, HaCaT. We demonstrated that 0.01 and 0.1 ng/ml mycolactone A/B are not able to induce apoptosis in primary human keratinocytes, but interfere with KSC wound repair. Moreover, the same toxin concentrations reduce cell proliferation of KSC and TAC and their ability to adhere to type IV collagen. HaCaT cells are more resistant to the toxin; nevertheless, they show a delayed woud repair when treated with 1 and 10 ng/ml mycolactone A/B. Moreover, these sub-apoptotic concentrations affect their ability to proliferate and adhere to collagen IV. Wound healing is a complex mechanism, which occurs "in vivo" as the outcome of many co-ordinated events. Sub-apoptotic mycolactone concentrations can affect essential mechanisms, which are required to achieve wound repair, such as adhesion, migration and proliferation of human keratinocytes.


Subject(s)
Cell Adhesion/drug effects , Cell Proliferation/drug effects , Keratinocytes/metabolism , Macrolides/pharmacology , Mycobacterium ulcerans/pathogenicity , Wound Healing/drug effects , Adult , Apoptosis/drug effects , Buruli Ulcer/microbiology , Buruli Ulcer/pathology , Cell Line , Collagen Type IV/metabolism , Humans , Macrolides/metabolism , Middle Aged , Stem Cells/drug effects , Stem Cells/metabolism , Wound Healing/physiology
5.
Neurosci Res ; 56(2): 145-53, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16872704

ABSTRACT

Cells require appropriate interaction with extracellular matrix proteins mediated by integrins to grow, differentiate and survive. Many cell types including nervous cells undergo anoikis, a substrate-dependent apoptosis, when adhesion is impaired. Resistance of tumors to cytotoxic drugs is probably due to disturbed apoptosis programs. The proteolytic enzymes caspases are the main executioners of apoptosis. It was reported that caspase-8 expression is deficient in some neuroblastoma cells. We demonstrated that human neuroblastoma cell line SK-B-BE, differentiated with retinoic acid, expressed caspases 3, 8 and 9. Caspases 8 and 3, but not caspase-9 were activated in SK-N-BE cells cultured in suspension or on aspecific adhesive substrate. Cell positive to caspase-8 were classified into four stages, by morphometric and densitometric parameters. The use of the specific caspase-8 inhibitor Z-IETD-FMK dramatically reduced apoptosis, demonstrating that caspase-8 is the upstream initiator caspase during SK-N-BE cells anoikis. Among matrix proteins, type I collagen is the most effective and fibronectin the least in delaying anoikis. The activation of caspases 8 and 3 by unligated integrins was dependent on the state of neuronal differentiation, since the most differentiated cell was the most vulnerable to anoikis. These data show that activation of caspase-8 is specifically required to promote anoikis in SK-N-BE neuroblastoma cells.


Subject(s)
Anoikis/physiology , Caspase 8/metabolism , Gene Expression/physiology , Analysis of Variance , Anoikis/drug effects , Antineoplastic Agents/pharmacology , Blotting, Western/methods , Caspase 3/metabolism , Cell Adhesion Molecules/pharmacology , Cell Differentiation/drug effects , Cell Line, Tumor , Cysteine Proteinase Inhibitors/pharmacology , Enzyme Activation/drug effects , Extracellular Matrix Proteins/pharmacology , Gene Expression/drug effects , Humans , Microscopy, Confocal/methods , Neuroblastoma , Oligopeptides/pharmacology , Time Factors , Tretinoin/pharmacology
6.
J Immunol Methods ; 285(1): 99-109, 2004 Feb 01.
Article in English | MEDLINE | ID: mdl-14871539

ABSTRACT

A large human nonimmune phage antibody library was screened by affinity chromatography to select single-chain antibodies directed against the human receptor tyrosine kinase (RTK) Ron. As antigen, we used a GST fusion protein (GST-IRP(-)) containing the whole intracellular portion of Ron except for the carboxyl-terminal arginine-proline-rich motif. One selected phage was highly specific for Ron when tested in an enzyme-linked immunosorbent assay (ELISA). We report here the immunological characterization of this anti-Ron single-chain antibody (sc7) and show that it recognizes both denatured and native forms of the receptor. The epitope bound by sc7 maps within the first 50 amino acid residues of the juxtamembrane domain of Ron. This monoclonal fragment does not cross-react with other receptor tyrosine kinases including the closely related human proto-oncogene Met. We demonstrate that the isolated antibody fragment interacts in vivo with the intracellular domain of Ron in mammalian cells.


Subject(s)
Antibodies/genetics , Receptor Protein-Tyrosine Kinases/immunology , Animals , Antibody Specificity , Antigen-Antibody Reactions , Base Sequence , Cell Line , Chromatography, Affinity , Cross Reactions , Dogs , Enzyme-Linked Immunosorbent Assay , Epitope Mapping , Epitopes/genetics , Humans , Immunoglobulin Variable Region/genetics , Peptide Library , Plasmids/genetics , Precipitin Tests , Proto-Oncogene Mas , Receptor Protein-Tyrosine Kinases/genetics , Receptor Protein-Tyrosine Kinases/isolation & purification , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology
7.
Microbes Infect ; 12(14-15): 1258-63, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20800104

ABSTRACT

The pathogenicity of Mycobacterium ulcerans (Buruli ulcer) depends on cytotoxic effect of its exotoxin mycolactone. Since epidermis represents a barrier against infectious agents and balanced apoptosis is essential in epidermal homeostasis, we explored if mycolactone A/B induces apoptosis on two human keratinocyte populations, stem cells (KSC) and transit amplifying cells (TAC), and on human keratinocyte line, HaCaT. Treatment of TAC with 1 and 10 ng/ml mycolactone-induced 60 and 90% apoptosis. KSC were more resistant than TAC: 50 and 75% of cells underwent apoptosis after 10 and 100 ng/ml toxin-treatment. Higher doses (1000 ng/ml) induced about 30% apoptosis on HaCaT. In contrast, mycolactone A/B was devoid of toxicity neither on human hepatoma HuH7 nor on human embryonic kidney HEK 293 T cell lines. In conclusion, mycolactone induces apoptosis in human keratinocytes, thus contributing to Buruli ulcer lesions development.


Subject(s)
Apoptosis , Keratinocytes/drug effects , Lactones/toxicity , Mycobacterium ulcerans/pathogenicity , Adult , Cells, Cultured , Hepatocytes/drug effects , Humans , Lactones/metabolism , Macrolides , Middle Aged , Mycobacterium ulcerans/metabolism
8.
Cells Tissues Organs ; 178(3): 139-45, 2004.
Article in English | MEDLINE | ID: mdl-15655331

ABSTRACT

Apoptosis is an active process of self-destruction, whereby cells undergo physiological cell death. It occurs during development and regulation of tissue homeostasis or as a result of changes in environmental stimuli. Chromatin condensation and nuclear fragmentation, which are typical features of apoptotic nuclei, are usually quantified by fluorescent DNA dyes. The present study reports a reliable method to analyze morphological apoptotic stages in cultured cells, using light microscopy. We used the human neuroblastoma cell line SK-N-BE as a model to study apoptosis induced by inadequate cell-matrix interactions. Apoptosis was detected on cells cultured for different time intervals on polyHEMA, poly-L-lysine or collagen I. Quantitative morphometric and densitometric analysis after hematoxylin nuclear staining and caspase-3 immunocytochemistry, as markers of occurring apoptosis, were performed. Our method identifies different stages of caspase-3 activation and the subsequent DNA fragmentation and condensation. This experimental procedure enables us to detect slight differences in apoptosis progression by morphological analysis.


Subject(s)
Apoptosis , Blotting, Western , Caspase 3 , Caspases/metabolism , Cell Adhesion , Cell Line, Tumor , Cell Nucleus/metabolism , Collagen Type I/metabolism , Coloring Agents , DNA Fragmentation , Densitometry , Extracellular Matrix/metabolism , Fluorescent Dyes , Hematoxylin , Humans , Immunohistochemistry , Indicators and Reagents , Neuroblastoma/pathology , Polylysine/metabolism , Propidium , Time Factors
9.
Mol Cell Neurosci ; 25(1): 1-8, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14962735

ABSTRACT

Integrin-mediated cell adhesion is required for cell survival and differentiation. Recently, integrins have been proposed as a target for beta-amyloid peptide (betaAP) neurotoxicity. We report here that treatment with betaAP (1-42) or with the active betaAP fragment (25-35) induced a great deal of apoptosis in SK-N-BE and SH-SY5Y cell lines. In the presence of either collagen I degrees, fibronectin, or laminin, betaAP toxicity was severely reduced. This protective effect seems to be mediated by integrins, because preincubation of neuroblastoma cells with antibodies directed against beta(1) and alpha(1) integrin subunits greatly enhanced betaAP-induced apoptosis. In addition, treatment with betaAP induced a strong reduction of beta(1) and alpha(1) integrin subunits expressed in plasma membrane, which occurred 3 h after treatment, before the appearance of the apoptotic morphology. The rapid downregulation of the alpha(1)beta(1) integrin was almost completely recovered 15-24 h after betaAP treatment and was not prevented by cycloheximide. In conclusion, our data indicate a relationship between betaAP neurotoxicity and modulation of alpha(1)beta(1) integrin expression, and support the hypothesis that aberrant integrin function may play a significant role in betaAP-mediated neurotoxicity.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/toxicity , Apoptosis/physiology , Brain/metabolism , Integrin beta1/metabolism , Neurons/metabolism , Alzheimer Disease/physiopathology , Antibodies/pharmacology , Apoptosis/drug effects , Brain/pathology , Brain/physiopathology , Cell Adhesion/drug effects , Cell Adhesion/physiology , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/physiology , Down-Regulation/drug effects , Down-Regulation/physiology , Extracellular Matrix Proteins/metabolism , Extracellular Matrix Proteins/pharmacology , Humans , Integrin alpha Chains/drug effects , Integrin alpha Chains/metabolism , Integrin alpha1beta1/drug effects , Integrin alpha1beta1/metabolism , Integrin beta1/drug effects , Neuroblastoma , Neurons/pathology , Peptide Fragments/toxicity , Protein Subunits/drug effects , Protein Subunits/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL